Isabelle Straumann

637 total citations · 1 hit paper
17 papers, 420 citations indexed

About

Isabelle Straumann is a scholar working on Clinical Psychology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Isabelle Straumann has authored 17 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Psychology, 8 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Isabelle Straumann's work include Psychedelics and Drug Studies (15 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Chemical synthesis and alkaloids (8 papers). Isabelle Straumann is often cited by papers focused on Psychedelics and Drug Studies (15 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Chemical synthesis and alkaloids (8 papers). Isabelle Straumann collaborates with scholars based in Switzerland, Netherlands and United States. Isabelle Straumann's co-authors include Matthias E. Liechti, Friederike Holze, Anne Eckert, A. Becker, Nimmy Varghese, Urs Duthaler, Laura Ley, Patrick Vizeli, Aaron Klaiber and Dino Luethi and has published in prestigious journals such as Scientific Reports, Neuropsychopharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Isabelle Straumann

14 papers receiving 418 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

2022 142 citations Friederike Holze, Laura Ley et al. Neuropsychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabelle Straumann Switzerland	9	402	266	199	58	58	17	420
Aaron Klaiber Switzerland	9	364 0.9×	257 1.0×	191 1.0×	43 0.7×	51 0.9×	15	392
Joseph P. Barsuglia United States	14	424 1.1×	215 0.8×	205 1.0×	43 0.7×	50 0.9×	18	570
Pål-Ørjan Johansen Norway	4	472 1.2×	243 0.9×	187 0.9×	42 0.7×	87 1.5×	4	488
Robin von Rotz Switzerland	10	282 0.7×	204 0.8×	184 0.9×	65 1.1×	28 0.5×	17	427
Joost J. Breeksema Netherlands	10	484 1.2×	270 1.0×	178 0.9×	41 0.7×	51 0.9×	22	561
Laura Kärtner United Kingdom	7	508 1.3×	335 1.3×	195 1.0×	22 0.4×	66 1.1×	10	546
Daniel Burmester Denmark	5	509 1.3×	313 1.2×	306 1.5×	28 0.5×	79 1.4×	6	543
Joshua Woolley United States	11	560 1.4×	390 1.5×	211 1.1×	24 0.4×	51 0.9×	22	609
Johannes T. Reckweg Netherlands	11	531 1.3×	299 1.1×	280 1.4×	66 1.1×	92 1.6×	23	599
Eduardo Ekman Schenberg Brazil	12	457 1.1×	218 0.8×	252 1.3×	23 0.4×	89 1.5×	21	564

Countries citing papers authored by Isabelle Straumann

Since Specialization

Citations

This map shows the geographic impact of Isabelle Straumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Straumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Straumann more than expected).

Fields of papers citing papers by Isabelle Straumann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Straumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Straumann. The network helps show where Isabelle Straumann may publish in the future.

Co-authorship network of co-authors of Isabelle Straumann

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Straumann. A scholar is included among the top collaborators of Isabelle Straumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Straumann. Isabelle Straumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hartmann, Matthias, Yasmin Schmid, A. Becker, et al.. (2025). The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research. Journal of Psychopharmacology. 4126446288–4126446288.

Straumann, Isabelle, Patrick Vizeli, Anne Eckert, et al.. (2025). Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants. Neuropsychopharmacology. 51(2). 476–485.

Schmid, Yasmin, Felix Müller, A. Becker, et al.. (2025). Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults. JAMA Psychiatry. 82(6). 555–555. 4 indexed citations

Becker, A., Isabelle Straumann, Jan Thomann, et al.. (2025). Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial. Clinical Pharmacology & Therapeutics. 117(6). 1784–1792. 6 indexed citations

Vizeli, Patrick, Erich Studerus, Friederike Holze, et al.. (2024). Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants. Translational Psychiatry. 14(1). 357–357. 9 indexed citations

Straumann, Isabelle, et al.. (2024). Safety pharmacology of acute psilocybin administration in healthy participants. Neuroscience Applied. 3. 104060–104060. 9 indexed citations

Klaiber, Aaron, Yasmin Schmid, A. Becker, et al.. (2024). Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects. Translational Psychiatry. 14(1). 395–395. 12 indexed citations

Luethi, Dino, Deborah Rudin, Isabelle Straumann, et al.. (2024). Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers. Journal of Chromatography B. 1238. 124123–124123. 5 indexed citations

Atila, Cihan, Isabelle Straumann, Patrick Vizeli, et al.. (2024). Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia. JAMA Network Open. 7(11). e2445278–e2445278. 4 indexed citations

10.

Straumann, Isabelle, Aaron Klaiber, Nimmy Varghese, et al.. (2024). Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants. Neuropsychopharmacology. 50(2). 362–371. 8 indexed citations

11.

Ley, Laura, Isabelle Straumann, A. Becker, et al.. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Neuroscience Applied. 2. 103377–103377.

12.

Ley, Laura, Friederike Holze, A. Becker, et al.. (2023). Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Neuropsychopharmacology. 48(11). 1659–1667. 75 indexed citations

13.

Ley, Laura, Isabelle Straumann, A. Becker, et al.. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Translational Psychiatry. 13(1). 172–172. 54 indexed citations

14.

Straumann, Isabelle, Laura Ley, Friederike Holze, et al.. (2023). Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants. Neuropsychopharmacology. 48(13). 1840–1848. 26 indexed citations

15.

Vizeli, Patrick, Isabelle Straumann, Urs Duthaler, et al.. (2022). Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects. Frontiers in Pharmacology. 13. 906639–906639. 26 indexed citations

16.

Holze, Friederike, Laura Ley, Felix Müller, et al.. (2022). Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology. 47(6). 1180–1187. 142 indexed citations breakdown →

17.

Vizeli, Patrick, Isabelle Straumann, Friederike Holze, et al.. (2021). Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis. Scientific Reports. 11(1). 10851–10851. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact